Recruiting Liver Disease Studies in New Haven
TReatment for ImmUne Mediated PathopHysiology
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will de...
Digoxin In NASH (CODIN)
Nonalcoholic steatohepatitis (NASH) is a severe subtype of nonalcoholic fatty liver disease (NAFLD) which affects 1 in 3 Americans. The mainstay of treatment for NASH, which was recently renamed metab...
About Liver Disease Clinical Trials in New Haven
Chronic liver disease encompasses conditions that damage the liver over time, including cirrhosis, hepatitis, and fatty liver disease. The liver plays a crucial role in digestion, metabolism, and detoxification. Treatment depends on the cause and may include medications, lifestyle changes, or liver transplant.
There are currently 2 liver disease clinical trials recruiting participants in New Haven, CONNECTICUT. These studies are seeking a combined 307 participants. Research is being sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Yale University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Liver Disease Clinical Trials in New Haven — FAQ
Are there liver disease clinical trials in New Haven?
Yes, there are 2 liver disease clinical trials currently recruiting in New Haven, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What liver disease treatments are being tested?
The 2 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for liver disease.
Data updated March 2, 2026 from ClinicalTrials.gov